Many clinicians have to make critical blood therapy decisions based on the limited snapshots provided by traditional tests – tests that simply weren’t designed to provide them with the relevant and comprehensive results they need.
The TEG 6s system provides rapid, comprehensive and accurate identification of a patient's hemostasis condition in a laboratory or site-of-care setting, which allows clinicians to drive treatment and monitoring decisions with confidence.
The TEG 6s system is an easy-to-use, single-cartridge system that helps to:
 |
Allow targeted blood therapy to optimize clinical outcomes, helping to reduce costs |
|
Reduce unnecessary transfusions |
|
Reduce surgical exploration for bleeding |
|
Deliver rapid results in time to make decisions |
In addition, when choosing Haemonetics' TEG technology, you have access to a comprehensive portfolio of programs and services to help maximize your investment, both clinically and economically.
Excerpted from COL-COPY-000918-US(AB), COL-COPY-000853-US(AB).